Search Results - peter+jurutka

14 Results

Sort By:

  1. Rapid MALDI-TOF MS-Based Characterization of Fecal Gut Microbiome in Irritable Bowel Syndrome
    Invention Description Irritable bowel syndrome (IBS) is a prevalent and multifactorial gastrointestinal disorder that affects 10-15% of the US population. Because the pathophysiology of IBS remains poorly understood, current diagnostic tools and treatments are limited, with diagnosis often relying on symptom-based assessments and exclusion of other...
    Published: 3/27/2026
    Inventor(s): Todd Sandrin, Peter Jurutka
    Keywords(s):  
    Category(s): Life Science (All LS Techs), Proteomic Assays/Reagents/Tools, Diagnostic Assays/Devices
  2. Multiomic Approaches to Pediatric Inflammatory Bowel Disease
    Invention Description Pediatric Inflammatory Bowel Disease (IBD), encompassing Crohn’s Disease and Ulcerative Colitis, presents significant clinical challenges due to its complex and heterogeneous nature, often leading to lifelong health complications. Current diagnostic and therapeutic strategies are limited by an incomplete understanding of...
    Published: 2/26/2026
    Inventor(s): Todd Sandrin, Peter Jurutka, Haiwei Gu, Brad Pasternak
    Keywords(s):  
    Category(s): Applied Technologies, Diagnostic Assays/Devices, Life Science (All LS Techs), Pharmaceuticals, Proteomic Assays/Reagents/Tools, Artificial Intelligence/Machine Learning
  3. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall, Arjan Van Der Vaart
    Keywords(s): Bio-Technology, Drug Screening
    Category(s): Life Science (All LS Techs), Cancer Therapeutics, Pharmaceuticals, Neurodegenerative Disease Technologies, Non-Cancer Therapeutics
  4. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions.There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s):  
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Non-Cancer Therapeutics, Neurodegenerative Disease Technologies, Pharmaceuticals
  5. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Simulation, Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  6. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s): Bio-Technology
    Category(s): Life Science (All LS Techs), Cancer Therapeutics, Pharmaceuticals, Neurodegenerative Disease Technologies, Non-Cancer Therapeutics
  7. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Pamela Marshall, Peter Jurutka, Carl Wagner
    Keywords(s): Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  8. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Peter Jurutka, Pamela Marshall
    Keywords(s): Cancer, Diabetes, Parkinson's Disease
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  9. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/26/2026
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Cancer, Diabetes, Parkinson's Disease
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals
  10. Compounds to Modulate Retinoid X Receptors
    The human retinoid X receptors (RXRs) function as transcriptional regulators, often in partnership with members of a larger nuclear receptor family of transcription factors. RXR agonists have been shown to modulate RXR transcription and activate or repress various biological pathways and effect therapeutic results for various conditions. There are a...
    Published: 2/13/2025
    Inventor(s): Carl Wagner, Pamela Marshall, Peter Jurutka
    Keywords(s): Therapeutics
    Category(s): Cancer Therapeutics, Life Science (All LS Techs), Neurodegenerative Disease Technologies, Non-Cancer Therapeutics, Pharmaceuticals

Search Inventions

Looking for a technology or invention to commercialize? Arizona State University has more than 300 technologies available for licensing. Start your search here or submit your own invention.